KRISTY WALKER: Open Payments
NPI 1164534491 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$687 in 35 payments from 11 companies in 2025. Trend: 2023 $973 · 2024 $728 · 2025 $687
Food & beverage: $687
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $248 |
| GENZYME CORPORATION | 5 | $152 |
| Novartis Pharmaceuticals Corporation | 4 | $100 |
| Lilly USA, LLC | 2 | $53 |
| UCB, Inc. | 2 | $32 |
| Incyte Corporation | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| LEO Pharma Inc. | 1 | $19 |
| Janssen Biotech, Inc. | 1 | $18 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $17 |
Products named: RINVOQ, DUPIXENT, SKYRIZI, COSENTYX, TALTZ, Rhapsido, Bimzelx, OPZELURA.
Industry payments across AR — which companies pay providers there.
